News

Novo Seeks Deals to Reverse Slide in Weight-Loss Market It Made
Novo Nordisk A/S is hunting for more early-stage deals to pad its pipeline of next-generation obesity drugs, as the drugmaker ...
Studies Address Muscle Loss Caused By GLP-1 Drugs
An experimental muscle-preserving drug called bimagrumab helped people taking semaglutide (Ozempic/Wegovy) keep their muscle ...
New Data Shows Just How Powerful the Next Weight-Loss Drugs May Be
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Ozempic Alternative May Offer Weight Loss Without Injections or Muscle Loss
A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...
New weight loss drug innovations could make medications more accessible
Doctors say there have been a number of developments with new weight loss drugs, which could make them easier for patients to ...
Amgen experimental weight-loss drug needs lower dose to limit side effects
Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like ...
Popular diabetes and weight-loss drug may reduce risk of dementia
Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...
Weight-loss jabs ‘could be hitting supermarket food sales’ as 4% of households now take them
The growing popularity of weight loss jabs could be affecting shopping habits in UK supermarkets, a leading research group ...
Experimental drug helps patients lose nearly a quarter of body weight in early trials
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...